Department of Internal Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
Cleve Clin J Med. 2013 Jan;80(1):49-60. doi: 10.3949/ccjm.80a.12084.
Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for females age 9 to 26 and for males age 11 to 26, yet vaccination rates are low. We review the host immune response, the data behind the recommendations for HPV vaccination, and the challenges of implementing the vaccination program.
接种人乳头瘤病毒(HPV)疫苗既安全又有效。建议 9 至 26 岁女性和 11 至 26 岁男性接种 HPV 疫苗,但疫苗接种率仍然较低。我们回顾了宿主免疫反应、HPV 疫苗接种建议背后的数据,以及实施疫苗接种计划所面临的挑战。